1. Report Overview
1.1 Global Precision Medicine Market Overview
1.1.1 Precision Medicine Market - Segmentation by Technology
1.1.2 Precision Medicine Market - Segmentation by Ecosystem Players
1.1.3 Precision Medicine Market - Segmentation by Therapeutic Application
1.1.4 Precision Medicine Market - Segmentation by Geography
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Precision Medicine
2.1 Evolution and Brief History of Precision Medicine
2.2 Key Benefits of Precision Medicine
2.3 Precision Medicine: Key Areas of Application
2.4 Precision Medicine: Key Elements
2.5 Precision Medicine: Different Type of Data Used by Big Data Companies
2.6 Precision Medicine: Area of Interest
3. Global Precision Medicine Market 2018-2028
3.1 Global Precision Medicine Market by Ecosystem, 2018-2028
3.2 Global Precision Medicine Market by Technology, 2018-2028
3.3 Global Precision Medicine Market by Therapeutic Application, 2018-2028
3.4 Global Precision Medicine Market by Geography, 2018-2028
4. Market Dynamics
4.1 Global Precision Medicine Market Drivers
4.1.1 Upcoming Technologies in Healthcare
4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies
4.1.3 Greater Involvement in Personal Healthcare
4.1.4 A Rise in Genetic Diseases
4.1.5 Growing Deamnd for Targeted Therapies
4.2 Global Precision Medicine Market Restraints
4.2.1 Limitations in Application due to Lack of Research and Evidences
4.2.2 Stringent Regulatory Framework and Reimbursement Policies
4.2.3 Stringent Regulations and Standards
4.2.4 Higher Cost of Diagnostic
4.2.5 Risk to Personal Data
4.2.6 Risk of failure of Software or Hardware
4.2.7 Lack of Knowledge and Awareness
4.3 Global Precision Medicine Market Opportunities
4.3.1 Increasing Awareness in Developing Economies
4.3.2 Reduction in the cost of Genome Sequencing
4.4 Regulatory Bodies
4.4.1 Food and Drug Administration (FDA)
4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA)
4.4.3 Therapeutic Goods Administration (TGA)-Australia
4.4.4 Conformité Européenne (CE)
4.5 Consortiums
4.6 Alliances/Associations
5. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Ecosystem Players
5.1 Introduction
5.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Ecosystem Players
5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2018-2028
5.2.1 Key Market Trends, Developments and Participants
5.2.1.1 Market Trends
5.2.1.2 Market Developments
5.2.1.3 Key Participants
5.3 Global Diagnostic Tools Companies Submarket Forecast 2018-2028
5.3.1 Key Market Trends, Developments and Participants
5.3.1.1 Market Trends
5.3.1.2 Market Developments
5.3.1.3 Key Participants
5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2018-2028
5.4.1 Key Market Trends, Developments And Participants
5.4.1.1 Market Trends
5.4.1.2 Market Developments
5.4.1.3 Key Participants
5.5 Global Clinical Laboratories Submarket Forecast 2018-2028
5.5.1 Key Market Trends, Developments And Participants
5.5.1.1 Regulatory bodies and compliances
5.5.1.2 Market Trends
5.5.1.3 Key Participants
6. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Technology
6.1 Introduction
6.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Technology
6.2 Global Companion Diagnostics Submarket Forecast 2018-2028
6.3 Global Biomarker-based Test Submarket Forecast 2018-2028
6.3.1 Role of Biobanking in Biomarker
6.3.2 Key Participants
6.4 Global Targeted Therapeutics Submarket Forecast 2018-2028
6.4.1 Key Participants
6.5 Global Pharmacogenomics Submarket Forecast 2018-2028
6.5.1 Key Market Trends, Developments And Participants
6.5.1.1 Market Trends
6.5.1.2 Market Developments
6.5.1.3 Key Participants
6.6 Global Molecular Diagnostics Submarket Forecast 2018-2028
6.7 Global Other Technology Submarket Forecast 2018-2028
6.8 Next-Generation Sequencing
6.9 Consumer Genomics
6.10 3D Printing
6.11 Prosthetics Market
6.12 Human Tissues Market
7. Global Precision Medicine Market Forecast 2018-2028: Segmented by Therapeutic Application
7.1 Introduction
7.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Therapeutic Application
7.2 Global Cancer Submarket Forecast 2018-2028
7.2.1 Types of cancer
7.2.2 Key Market Trends, Developments & Participants
7.2.2.1 Market Trends
7.2.2.2 Market Developments
7.2.2.3 Key Participants
7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2018-2028
7.3.1 Drugs & Tests
7.3.2 Market Trends & Market Developments
7.3.2.1 Market trend
7.3.2.2 Market Developments
7.3.2.3 Key Participants
7.4 Global Central Nervous System Market Forecast 2018-2028
7.4.1 Neurological
7.4.1.1 Neurological Drugs & Tests
7.4.2 Psychiatric Disorders
7.4.2.1 Psychiatric Disorder Drugs & Tests
7.4.3 Market tends & Market Developments
7.4.3.1 Market Trends
7.4.3.2 Key Participants
7.5 Global Infectious Diseases Submarket Forecast 2018-2028
7.5.1 Infectious Diseases Drugs & Tests
7.5.2 Market Developments & participants
7.5.2.1 Key Developments
7.5.2.2 Key Participants
7.6 Global Other Therapeutic Application Submarket Forecast 2018-2028
7.6.2 Market trends, Developments & Participants
7.6.2.1 Market Trends
7.6.2.2 Key Developments
7.6.2.3 Key Participants
8. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Geography
8.1 Introduction
8.2 The Americas Precision Medicine Market Forecast 2018-2028
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.1.3 Key Market Trends, Developments and Participants
8.2.1.3.1 Regulations and Compliances
8.2.1.3.2 Market Trends
8.2.1.3.3 Market Developments
8.2.1.4 Key Participants
8.2.2 South America
8.2.2.1 Key Market Trends, Developments and Participants
8.2.2.1.1 Regulations and Compliances
8.2.2.1.2 Market Trends
8.2.2.2 Key Participants
8.3 Europe Precision Medicine Market Forecast 2018-2028
8.3.1 Key Market Trends, Developments And Participants
8.3.1.1 Regulations and Compliances
8.3.1.2 Market Developments
8.3.1.3 Key Participants
8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2018-2028
8.4.1 Key Market Trends, Developments and Participants
8.4.1.1 Market Developments
8.4.1.2 Key Participants
8.5 Rest of the World/Midde East & Africa (MEA) Precision Medicine Market Forecast 2018-2028
8.5.3 Key Market Developments And Participants
8.5.3.1 Market Developments
8.5.3.2 Key Participants
9. Market Analysis
9.1 Porter's Five Forces Analysis
9.1.1 Bargaining Power of Supplier
9.1.2 Bargaining Power of Buyer
9.1.3 Industry Rivalry
9.1.4 Threat of New Entrants
9.1.5 Threat of Substitutes
9.2 Value Chain Analysis
9.2.1 Device Manufacturer & Drug Producers
9.2.2 Healthcare Providers
9.2.3 Healthcare IT Or Big Data Companies
9.2.4 Regulators
9.2.5 Third Party Payers
9.2.6 Patients
10. Company Profiles
10.1 Abbott Laboratories: Overview
10.1.1 Abbott Laboratories: Products & Service
10.1.2 Abbott Laboratories: Key Developments
10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy
10.2 GE Healthcare: Overview
10.2.1 GE Healthcare: Products & Service
10.2.2 GE Healthcare: Key Developments
10.2.3 GE Healthcare: Future Outlook and Growth Strategy
10.3 GlaxoSmithKline plc: Overview
10.3.1 GlaxoSmithKline plc: Products & Service
10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy
10.4 Johnson & Johnson: Overview
10.4.1 Johnson & Johnson: Products & Service
10.4.2 Johnson & Johnson: Key Developments
10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy
10.5 Pfizer Inc.: Overview
10.5.1 Pfizer Inc.: Products & Service
10.5.2 Pfizer Inc.: Key Developments
10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy
10.6 Laboratory Corporation of America Holdings Overview
10.6.1 Laboratory Corporation of America Holdings: Products & Service
10.6.2 Laboratory Corporation of America Holdings: Key Developments
10.7 Danaher Corporation: Overview
10.7.1 Danaher Corporation: Products & Service
10.7.2 Danaher Corporation: Key Developments
10.7.3 Danaher Corporation: Future Outlook and Growth Strategy
11. Competitive Landscape
11.1 Introduction
11.1.1 Partnerships, Collaborations and Joint Ventures
11.1.2 Product Launch/Development
11.1.3 Acquisitions
11.1.4 Expansion
11.1.5 Patents, Approvals and Certifications
11.1.6 Others
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 2.1 Key Benefits of Precision Medicine
Table 2.2 Key Elements of Precision Medicine
Table 4.1 Key Benefits of Precision Medicine for Patients
Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry
Table 4.3 Key Consortiums in the Precision Medicine Industry
Table 4.4 Key Alliances/Associations in the Precision Medicine Industry
Table 5.1 Global Precision Medicine Market Forecast by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.2 Global Pharma & Biotech Companies Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.3 Global Pharma & Biotech Companies Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.4 Global Pharma & Biotech Companies Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.5 Key Developments In Pharma & Biotech Companies
Table 5.6 Global Diagnostic Tool Companies Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.7 Global Diagnostic Tool Companies Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.8 Global Diagnostic Tool Companies Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.9 Key Developments In Diagnostic Companies
Table 5.10 Global Healthcare ITs/Big Data Submarket by Technology: Revenue ($m), AGR (%), CAGR (%)
Table 5.11 Global Healthcare ITs/Big Data Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%)
Table 5.12 Global Healthcare ITs/Big Data Submarket by Geography: Revenue ($m), AGR (%), CAGR (%)
Table 5.13 Key Developments In Healthcare IT/Big Data Companies
Table 5.14 Clinical Laboratories: Global Precision Medicine Market Value by Sub-Market Types: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 5.15 Clinical Laboratories: Global Precision Medicine Market Value by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%)
Table 5.16 Clinical Laboratories: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.1 Global Precision Medicine Market by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.2 Global Companion Diagnostics Subamarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.3 Global Companion Diagnostics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.4 List Of Approved Companion Diagnostic Devices
Table 6.5 Global Biomarker-based Test Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.6 Global Biomarker-based Test Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.7 List of Biobanks
Table 6.8 Examples Of Biobanking Initiatives Across Selected OECD Countries
Table 6.9 Global Targeted Therapeutic Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.10 Global Targeted Therapeutic Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.11 Global Pharmacogenomics Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.12 Global Pharmacogenomics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.13 Market Developments
Table 6.14 Global Molecular Diagnostics Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.15 Global Molecular Diagnostics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.16 Some Examples of Human Genetic Tests That Have Been Approved by the FDA
Table 6.17 Some Examples of Microbial Tests That Have Been Approved by the FDA
Table 6.18 Global Others Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.19 Global Others Submarket Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.1 Global Precision Medicine Market by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.2 Global Cancer Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.3 Global Cancer Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.4 Global Cancer Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.5 Precision Medicine Drugs And Relevant Genes: Oncology
Table 7.6 Precision Medicine Genetic Tests With Respect To Oncology
Table 7.7 Key Developments
Table 7.8 Global Cardiovascular Diseases Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.9 Global Cardiovascular Diseases Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.10 Global Cardiovascular Diseases Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.11 Precision Medicine Drugs And Relevant Genes: Cardiovascular
Table 7.12 Precision Medicine Genetic Tests With Respect to Cardiovascular
Table 7.13 Key Developments
Table 7.14 Global CNS Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%) 2017-2028
Table 7.15 Global CNS Submarket by Technology: Revenue ($m), AGR (%), CAGR (%) 2017-2028
Table 7.16 CNS: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%) 2017-2028
Table 7.17 Precision Medicine Drugs And Relevant Genes: Neurology
Table 7.18 Precision Medicine Drugs And Relevantgenes: Psychiatric Disorders
Table 7.19 Precision Medicine Genetic Tests With Respect to Psychiatric Disorders
Table 7.20 Psychiatric Disorders: Key Developments
Table 7.21 Global Infectious Disease Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%)
Table 7.22 Global Infectious Disease Submarket by Technology: Revenue ($m), AGR (%), CAGR (%)
Table 7.23 Global Infectious Disease Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.24 Precision Medicine Drugs and Relevant Genes: Infectious Diseases
Table 7.25 Key Developments
Table 7.26 Global Other Therapeutic Application by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%) 2017-2028
Table 7.27 Global Other Therapeutic Application by Technology: Revenue ($m), AGR (%), CAGR (%) 2017-2028
Table 7.28 Other Therapeutics: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 7.29 Precision Medicine Drugs And Relevant Genes: Other Diseases
Table 7.30 Precision Medicine Genetic Tests With Respect To Other Diseases
Table 7.31 Key Developments
Table 8.1 Global Precision Medicine Market by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.2 Americas Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.3 Americas Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.4 Market Developments
Table 8.5 Europe Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.6 Europe Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.7 Market Developments
Table 8.8 APAC Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.9 APAC Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.10 Market Developments
Table 8.11 ROW Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.12 ROW Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 8.13 Market Developments
Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers
Table 9.2 Key Factors Affecting the Bargaining Power of Buyer
Table 9.3 Key Factors Affecting the Industry Rivalry
Table 9.4 Key Factors Affecting the Threat of New Entrants
Table 9.5 Key Factors Affecting the Threat of Substitutes
Table 10.1 Abbott Laboratories Overview
Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income
Table 10.3 Abbott Laboratories : Key Developments
Table 10.4 GE Healthcare Overview
Table 10.5 GE Healthcare: 5-year Revenue, Profit
Table 10.6 GE Healthcare: Key Developments
Table 10.7 GlaxoSmithKline plc: Overview
Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax)
Table 10.7 Johnson & Johnson: Overview
Table 10.8 Johnson & Johnson: 5-year Revenue, Net Earnings
Table 10.9 Johnson & Johnson: Key Developments
Table 10.10 Pfizer Inc. Overview
Table 10.11 Pfizer Inc.: 5-year Revenue, Net Income, Operating Income
Table 10.12 Pfizer Inc: Key Developments
Table 10.13 Laboratory Corporation of America Holdings: Overview
Table 10.14 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income
Table 10.15 Laboratory Corporation: Key Developments
Table 10.16 Danaher Corporation: Overview
Table 10.17 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit
Table 10.18 Danaher Corporation: Key Developments
Table 11.1 Key Partnerships, Collaborations and Joint Ventures
Table 11.2 Key Product Developments
Table 11.3 Key Acquistions
Table 11.4 Key Expansion
Table 11.5 Key Patents, Approvals And Certifications
Table 11.6 Key Other Events
List of Figures
Figure 1.1 Global Precision Medicine Market - Segmentation by Technology
Figure 1.2 Global Precision Medicine Market - Segmentation by Ecosystem
Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application
Figure 1.4 Global Precision Medicine Market - Segmentation by Geography
Figure 2.1 History of Precision Medicine
Figure 2.2 Key Areas of Application of Precision Medicine
Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine
Figure 2.4 Key Areas of Interest of Precision Medicine
Figure 3.1 Global Precision Medicine Market Share by Ecosystem: Revenue ($bn), 2017-2028
Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2017-2028
Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2017-2028
Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2017-2028
Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards
Figure 4.2 FDA's Role in Precision Medicine
Figure 5.1 Global Precision Medicine Market by Ecosystem Players
Figure 5.2 Role Of Pharmaceuticals And Biotech Companies
Figure 5.3 Challenges Faced by Pharma & Biotech Companies
Figure 5.4 Diagnostic Tests Benefits for Stakeholders
Figure 5.5 Challenges Faced by Diagnostic Companies
Figure 5.6 Benefits Of Big Data
Figure 5.7 Transformation Of Medicine
Figure 5.8 Basic Ingredients Provided by Big Data For Precision Medicine
Figure 5.9 Challenges Faced by Big Data Companies
Figure 5.10 OECD Recommendations On The Governance Of Clinical Trials
Figure 6.1 Types Of Precision Medicine Sub-Market
Figure 6.2 Benefits of Companion Diagnostics
Figure 6.3 Function Of Biomarkers
Figure 6.4 Biobanks Services
Figure 6.5 Development In PGx
Figure 6.6 Model Systems Used In PGx
Figure 6.7 Challenges Of PGx Studies
Figure 6.8 Type of Molecular Diagnostics Test
Figure 6.9 Molecular Diagnostics: Application
Figure 6.10 Molecular Diagnostics: Benefits
Figure 7.1 Global Precision Medicine Market by Therapeutics
Figure 8.1 Global Precision Medicine Market Classification by Geography
Figure 8.2 Key Drivers For Precision Medicine: North America
Figure 8.3 Objectives of the Precision Medicine Initiative
Figure 8.4 APAC: Market Challenges
Figure 9.1 Precision Medicine Market Porter's Five Forces Analysis, 2017
Figure 9.2 Precision Medicine Market Value Chain
Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2017
Figure 10.2 Abbott Laboratories: Sales by Region (%), 2017
Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017
Figure 10.4 GE Healthcare: Sales by Geography (%), 2017
Figure 10.5 GlaxoSmithKline plc: Sales by Business
Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017
Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017
Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017
Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2017
Figure 10.10 Pfizer Inc.: Sales by Region (%), 2017
Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017
Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017
Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017
Figure 10.14 Danaher Corporation: Sales by Region (%), 2017
Figure 11.1 Precision Medicine Market Key Development Strategies
